(Q40299140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Massimo Donadelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Paolo Piacentini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chiara Costanzo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Patrick S Moore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marta Palmieri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

28 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

448

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

797-804

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568310%20AND%20SRC:MED&resulttype=core&format=json

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

18 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-006-0173-X

The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-006-0173-X

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

21 January 2018

1 reference

12 December 2020

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation

1 reference

12 December 2020

Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad.

1 reference

12 December 2020

A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.

1 reference

12 December 2020

Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer

1 reference

12 December 2020

Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity

1 reference

12 December 2020

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms

1 reference

12 December 2020

Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A.

1 reference

12 December 2020

New perspectives in the management of pancreas cancer

1 reference

12 December 2020

Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.

1 reference

12 December 2020

1 reference

12 December 2020

A phase I trial of depsipeptide (FR901228) in patients with advanced cancer.

1 reference

12 December 2020

Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

1 reference

12 December 2020

Adjuvant therapy in pancreatic cancer: historical and current perspectives

1 reference

12 December 2020

A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

1 reference

12 December 2020

Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer

1 reference

12 December 2020

Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11

1 reference

12 December 2020

Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells.

1 reference

12 December 2020

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines

1 reference

12 December 2020

Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.

1 reference

12 December 2020

p53 and K-RAS alterations in pancreatic epithelial cell lesions

1 reference

12 December 2020

Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes

1 reference

12 December 2020

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

1 reference

12 December 2020

Oxaliplatin: mechanism of action and antineoplastic activity

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Oxaliplatin: available data in non-colorectal gastrointestinal malignancies

1 reference

12 December 2020